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Abstract
Objectives: Household contacts (HHCs) of pulmonary tuberculosis patients are at high risk of Mycobacterium tuberculosis
infection and early disease development. Identification of individuals at risk of tuberculosis disease is a desirable goal for
tuberculosis control. Interferon-gamma release assays (IGRAs) using specific M. tuberculosis antigens provide an alternative
to tuberculin skin testing (TST) for infection detection. Additionally, the levels of IFNc produced in response to these
antigens may have prognostic value. We estimated the prevalence of M. tuberculosis infection by IGRA and TST in HHCs and
their source population (SP), and assessed whether IFNc levels in HHCs correlate with tuberculosis development.
Methods: A cohort of 2060 HHCs was followed for 2–3 years after exposure to a tuberculosis case. Besides TST, IFNc
responses to mycobacterial antigens: CFP, CFP-10, HspX and Ag85A were assessed in 7-days whole blood cultures and
compared to 766 individuals from the SP in Medellı ´n, Colombia. Isoniazid prophylaxis was not offered to child contacts
because Colombian tuberculosis regulations consider it only in children under 5 years, TST positive without BCG
vaccination.
Results: Using TST 65.9% of HHCs and 42.7% subjects from the SP were positive (OR 2.60, p,0.0001). IFNc response to CFP-
10, a biomarker of M. tuberculosis infection, tested positive in 66.3% HHCs and 24.3% from the SP (OR=6.07, p,0.0001).
Tuberculosis incidence rate was 7.0/1000 person years. Children ,5 years accounted for 21.6% of incident cases. No
significant difference was found between positive and negative IFNc responders to CFP-10 (HR 1.82 95% CI 0.79–4.20
p=0.16). However, a significant trend for tuberculosis development amongst high HHC IFNc producers was observed (trend
Log rank p=0.007).
Discussion: CFP-10-induced IFNc production is useful to establish tuberculosis infection prevalence amongst HHC and
identify those at highest risk of disease. The high tuberculosis incidence amongst children supports administration of
chemoprohylaxis to child contacts regardless of BCG vaccination.
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Introduction
Tuberculosis (TB) is still a major cause of illness and death
worldwide. In 2006, there were an estimated 9.2 million new
cases of the disease and more than two billion people were
expected to be infected with Mycobacterium tuberculosis [1].
Mathematical projections estimate that, even with sustained
implementation of conventional control interventions, TB is not
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the prevalence by 2015 and eliminating it by 2050 [2]. In
addition to providing supervised therapy to cases, new tools to
prevent infection and reduce transmission are required to
accelerate progress in TB control [3]. In countries with medium
to high TB prevalence, where a large percentage of cases are due
to recent transmission, household contacts (HHCs) of pulmonary
TB cases are at particularly high risk [4] and constitute an
important target for early preventive alternatives in TB control
[5]. Since the highest risk of disease development concentrates
during the first two years after infection, identification of factors
associated with infection and prognosis of disease development in
recently exposed individuals is a highly instrumental and
desirable approach for improving TB control [5].Traditional
models of TB epidemiology based on longitudinal studies were
performed several decades ago, using tuberculin skin testing
(TST), indicate that 5–10% of recently infected contacts develop
active disease within the subsequent 2–5 years after exposure to
an infectious source, while another 5–10% percent develop TB
some time during the rest of their lives [6]. However, there is a
need of information coming from population based studies in
disease endemic settings to revise such estimates under current
epidemiological conditions.
Traditionally, M. tuberculosis infection levels have been
estimated using TST; however, the purified protein derivative
(PPD) is a mix of more than 200 proteins which presents cross
reactivity with Mb o v i sBCG and most environmental mycobac-
teria [7]. Comparative analysis of the mycobacterial genome
allowed the identification of antigens coded by a region present
in M. tuberculosis but absent in all BCG strains and all but four
environmental mycobacteria [8,9]. This region of differentiation,
RD1, encodes CFP-10 and ESAT-6, which induce IFNc
production in mononuclear cells or whole blood cultures of
infected individuals, thus IFNc release assays (IGRAs) have been
extensively used to diagnose latent TB infection (LTBI) [10]. Use
of these highly specific assays in countries with high levels of
endemicity, where BCG is still widely administered, would allow
for a more refined understanding and identification of the factors
associated with M. tuberculosis infection. Although the potential
of RD1 antigens for establishing disease prognosis has
been proposed [11] and some studies have begun to address it
[12–16], there is still a lack of evidence from representative,
population based studies.
In addition to RD1 antigens, several proteins involved in
mycobacterial latency and immune reactivity have been charac-
terized: HspX, also known as a-crystalline, is up-regulated during
the bacterial stationary phase of growth, and is thought to be a key
player in maintaining latency in the human host [17]. Antigen 85A
(Ag85A) is a potent immunogen that has been proposed as a
vaccine candidate [18].
The present study addresses whether IFNc production in
response to CFP-10, alone or in combination with HspX,
Ag85A and CFP (a non-specific M. tuberculosis culture filtrate
protein preparation) could identify HHCs at highest risk of
developing disease within the first two years after exposure to an
infectious source in Medellı ´n, Colombia. Medellı ´n’s greater
metropolitan area has a population of more than four million
inhabitants [19] with a TB incidence of 27.7/100,000 (http://
www.dssa.gov.co/htm/event_3.html). We present evidence
that, as measured by IFNc response to CFP-10, there is a high
prevalence of infection in HHCs and that high HHC IFNc
producers in response to CFP-10 are at higher risk of developing
TB than lower producers early after exposure to a pulmonary
TB case.
Methods
Ethics Statement
All study’s procedures and written consent forms were approved
by the ethics review board of Universidad de Antioquia’s Facultad
de Medicina.
Participants
A cohort of 2060 household contacts of smear positive
pulmonary TB cases was assembled in Medellı ´n’s greater
metropolitan area in Colombia, between March of 2005 and
December 2006 (Figure 1). Sample size was estimated expecting
50% infection and 5% TB incidence amongst infected HHCs
during the first 2 years after exposure. Under these conditions, a
cohort of 2000 HHCs would allow for 82% power and 95%
confidence to detect a difference of at least 0.80 in the TB
incidence of the two groups of IFNc producers (non-responders vs.
responders) at baseline. Four hundred and thirty three (433)
sputum smear positive pulmonary TB patients were recruited at
the health centres where they were diagnosed. Mycobacterial
culture was performed to 396/433 (91.5%) samples and 6.3%
were culture negative. Only cases that were older than 15 years of
age and had at least one HHC were considered as index cases and
asked to participate. Bacteriological confirmation of TB was
performed by detection of acid fast bacilli (AFB) at the local TB
control program’s laboratories and confirmed by the research
team’s Microbiology laboratory at Corporacio ´n para Investiga-
ciones Biolo ´gicas (CIB) by sputum microscopy and culture.
Patients were interviewed by a physician and an auxiliary nurse
specifically trained for enrollment and follow-up of study subjects.
Informed consent was obtained for participation in the study as
Figure 1. Study profile. HHCs=Household contacts, IGRA=IFNc
Release Assay, TST=Tuberculin Skin Test, SP=source population, CFP-
10=Culture Filtrate Protein-10.
doi:10.1371/journal.pone.0008257.g001
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After written informed consent was provided, a structured
interview was performed to ascertain the number of household
contacts the patients had during the symptomatic period and first
two weeks on TB medications, as well as exposure information
related to the index case.
After approval by the index case, household contacts were
visited and their eligibility was verified excluding those that had
immediate plans to live outside the study area. After offering a
thorough description of the study, a written informed consent was
obtained from HHCs, and in minors, consent was granted by
parents or responsible adult guardians. Demographic, social and
exposure information was collected by administration of a
structured questionnaire and physical household conditions such
as number of rooms, total and index case’s room area and volume,
as well as number of doors, patios and windows in the household,
were recorded. Socioeconomic strata (SES) defined by the local
public services provider (Empresas Pu ´blicas de Medellı ´n) were also
registered. Time and magnitude of HHCs exposure to the index
case was ascertained. A household contact was considered to be
someone who had spent time regularly (weekly) in the same
household as the index case for at least a month prior to the time
when the index cases’ diagnosis was confirmed. Inclusion criteria
were: meeting the household contact definition, not having
immediate plans to live outside Medellı ´n’s metropolitan area
and provision of written informed consent. Exclusion criteria were:
high level of suspicion of active TB or diagnostic work up for TB in
progress.
Health status upon enrollment was established by physical
examination performed by a physician and specific enquiry on
immunosuppressive conditions related to medication intake and
concurrent diseases. Contacts that were found to have symptoms
suggestive of TB were studied to diagnose or rule out the presence
of disease upon study entry. A co- prevalent case was defined as
someone who was diagnosed with TB within two months after
enrollment of the index case [14]. Blood samples were obtained
from HHCs and processed as described below. Also, TST was
performed in a consecutive sample of 502 HHCs after blood was
obtained (see below). In addition to BCG scar ascertainment,
mothers and adults responsible for all children in the study were
asked to provide a copy of the child’s vaccination certificate and
inquired whether children had received vaccinations at birth.
Participants were followed every 3 months by phone, every 6
months by house visits and when they reported having TB
compatible symptoms. In addition to extensive health education
about TB, two telephone numbers were provided to study
participants so they could report any signs or symptoms compatible
with TB as soon as they became apparent. Whenever there was
clinical suspicion of TB, particularly in TST positive children, all
diagnostic procedures were oriented towards achievement of early
disease detection. If diagnostic aids were not readily available
through the TB Control Program, these were paid and provided by
the study. HHCs that presented clinical symptoms and signs of
pulmonary TB during follow-up were studied by chest X-rays and
confirmed by AFB staining and culture from sputum samples in
adults and gastric aspirate in children. Extrapulmonary and
paediatric TB cases were diagnosed following American Thoracic
Society’s [20] and the Stop TB Partnership Childhood TB
subgroup’s guidelines [21], respectively. The definitive diagnosis
of secondary TB cases in children was established by two
experienced infectious disease paediatricians (CA, AB). All cases
confirmed were referred to the local TB Control Program.
A cross-sectional survey was performed by random sampling of
the source population (SP) in the areas which contributed most of
the households enrolled in the HHC cohort. Four communities
from Medellı ´n, comprising the North-Eastern zone of the city, and
two neighbouring towns (Bello and Itaguı ´) were sampled
independently, stratifying by age and sex so as to reflect the
distribution of these variables in the cohort’s population. A
probabilistic multistage sampling strategy was performed taking
individual subjects as the sampling unit and the three stages being
county, household, and individual. One person per household was
selected on the basis of pre-established age and sex quotas. After
obtaining written informed consent, each person was interviewed
and a structured questionnaire was completed which contained
demographic and TB risk related information. Ten millilitres of
venous blood were also drawn and TST was performed on each
study participant. Of 771 individuals sampled, 766 had complete
information. These were estimated to allow for comparisons with
95% confidence level and 80% power.
Mycobacterium tuberculosis Culture and Identification
M. tuberculosis cultures from index and incident active TB cases
were derived from sputum samples in adults and from gastric
fluid aspirate in children. Mycobacterial culture was performed
in liquid medium (MGIT960 H BD) and Lowenstein-Jensen (LJ)
agar by standard procedures. Identification of mycobacteria
species were performed using conventional phenotypic tests
[22].
Whole Blood Cultures
The method described by Dockrell et al [23,24] was used for
whole blood culture from all HHCs, SP subjects, all incident cases
at the time of TB diagnosis and the 50 HHCs controls that did not
develop active tuberculosis after two years of follow-up. In
addition, HHCs who were non-responders at the first assessment
were studied again 3–4 months later. Five to ten millilitres of
venous blood were collected in vacuum-tainers containing sodium
heparin. Whole blood was diluted 1:10 in RPMI-1640 culture
medium (Invitrogen, Grand Island, NY), supplemented with
100 U/ml of penicillin, 1 mg/ml of streptomycin and 2 mM L-
glutamine. Diluted blood (200 ml/well) was dispensed in 96-well
plates (Corning Costar Inc, Corning, NY, USA) and stimulated
with 10 mg/ml of M. tuberculosis culture filtrate protein (CFP),
5 mg/ml of recombinant CFP-10, a M. tuberculosis specific RD1
antigen [8,9], 5 mg/ml of recombinant Ag85A, a T-cell immuno-
dominant antigen [18], and 10 mg/ml of recombinant alpha
crystallin (HspX) a latency-associated antigen [17]. All antigens
were produced and provided by Colorado State University’s
Mycobacteria Research Laboratory, Fort Collins, CO through the
‘‘Tuberculosis Vaccine Testing and Research Material Contract
No. HHSN26266400091c. Non stimulated wells were used as
controls. Cultures were incubated at 37uC and 5% CO2 for 7 days.
At the end of the incubation period, supernatants were collected
and stored at 270uC until used.
Measurement of IFNc by ELISA
IFNc concentration in the culture supernatant of mycobacterial
stimulated and non stimulated whole blood cultures were
determined by ELISA using a commercial kit (Duo-set R&D
Systems, Minneapolis, MN) following manufacturer’s instructions.
Readings were performed in an ELISA reader (ELx800NB,
BioTek Instruments Inc, Winooski, VT) at 450nm and IFNc
concentration was established against a standard curve with
known dilutions of the cytokine within a 15–1,000 pg/ml range.
Supernatants exhibiting concentrations above the range included
for the standard curve were diluted and quantified again.
IFNc and TB Prediction
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Two IU of RT23 tuberculin (Staten Serum Institute, Copenha-
gen, Denmark) in 100 ml were injected intradermally on the volar
face of the left forearm. Transversal diameters of induration were
measured 48–72 h later using the ‘‘ballpoint pen method’’ and
following a pre-established standard operating procedure.
Statistical Methods
Data was entered in a Microsoft Access database and statistical
analysis was performed using SPSS version 17 (SPSS Inc. Chicago
IL, USA), STATA 10.1 (StataCorp, College Station TX, USA)
and Prism software version 5 (GraphPad San Diego CA, USA).
Data entry, query generation and correction were performed on a
daily basis. To establish the cut-off values for IFNc production, the
type of probability distribution that best fit the data from non
stimulated cultures was identified as Gamma through visual
inspection of Q-Q plots and Kolmogorov–Smirnov hypothesis
testing [25]. Estimators for shape (a) and scale (b) parameters were
estimated to be 0.025 and 0.042 respectively. The cut-off was
established at 22 pg/mL after adjustment for within data
correlations and allowing for an area under the curve of 99.9%.
For estimation of geometric means, 1 was added to all IFNc
values. Net IFNc production was calculated by subtracting values
in non-stimulated cultures from stimulated ones.
Two different data sets were used for analysis of HHCs. The first
included all HHCs with baseline assessments of IFNc responses to
mycobacterial antigens and the study of factors associated with IFNc
production in response to CFP-10, used as a surrogate biomarker of
exposure to M.tuberculosisinfection[26].Thissetwasusedtocompare
HHCs to individuals from the source population. A second data set
was used for analysis relating to disease development. The latter
excluded co-prevalent cases and individuals without baseline IGRA
results. After descriptive and bivariate analyses, a multivariate logistic
regression model was constructed to assess factors associated with
baseline M. tuberculosis infection levels in HHCs and SP. Adjustment
for within household correlations was performed with Generalized
Estimating Equations [27]. Categorical variable colinearity was
assessed using Kendall’s tau-B with a=0.05. Odds ratios (ORs) were
used toestimatethelikelihoodofinfectioninHHCscomparedtothat
of individuals from the SP, using TST and IFNc response to CFP-10
as surrogate markers of M. tuberculosis infection. The predictive
potential of IFNc response to mycobacterial antigens was first
explored comparing the geometric means of IFNc levels and the
proportion of responders versus non-responders to each antigen in
incident and non-incident HHCs. In addition, since it had recently
been proposed by Andersen etal[11] that the risk of developing active
TB varies according to the levels of IFNc produced in response to
RD1 antigens, we calculated this risk using the categories suggested
by these authors, but adding a new one of non responders based on
our cut-off. Thus, the following 4 categories were established:
negative (,22 pg/mL), low (22–99 pg/mL), medium (100–999 pg/
mL) and high ($1000 pg/mL). Data analyses for assessment of
diseaseprognosiswereperformedusingKaplan-Meiercurves,hazard
ratio (HR) and cumulative incidence rate estimations as well as
Poisson multivariate regression (data not shown).
Ethical Aspects
All study’s procedures and written consent forms were approved
by the Ethics Committee of Universidad de Antioquia’s Facultad
de Medicina; the study was also approved by the local health
authorities (Direccio ´n Seccional de Salud de Antioquia and the
Secretarı ´a de Salud de Medellı ´n). At present the Colombian TB
Control Program does not have a policy of offering Isoniazid
Preventive Therapy (IPT), except in child contacts under 5 years
of age, who are TST positive ($10 mm) and have no evidence of
BCG vaccination [28]. Given that several international guidelines
clearly state the importance of offering IPT to young contacts
[29–31], we inquired specifically about the possibility of offering
IPT to child contacts and program officials reemphasized that
Colombian regulations only allow IPT administration to TST
positive children without BCG vaccination, Since in Colombia
anti - tuberculous treatment can only be provided through the
National Tuberculosis Control Program (NTP) we were unable to
provide IPT to all child contacts.
It is worth noting that, in addition to regular follow up activities,
monthly nutritional supplements were offered to all child contacts
under 5 years old through the governmental MANA program
(Mejoramiento Alimentario y Nutricional de Antioquia). This
allowed us to monitor closelytheir health conditions through physical
examinations and mother’s enquiries. Health education activities,
particularly regarding TB prevention and use of these supplements to
improve nutrition, were also part of the activities provided every time
children were evaluated and given supplements.
Role of the Funding Sources
The study sponsors were not involved in study design, data
collection, interpretation and analysis or in writing the manuscript.
The corresponding author had full access to all data collected and
had responsibility for the decision to submit the final draft for
publication.
Results
Demographic and Clinical Characteristics of Index Cases,
HHC and Source Population
Of 433 index cases recruited, 366 had HHCs that met inclusion
criteria. Index cases were mostly (56.6%) men between 15 and 49
years of age (74.8%), predominantly belonging to the lowest 3
socioeconomic levels (63.4%) and 10.1% of them reported having
had TB previously. Seventy two percent (72.2%) had BCG scars
(Table 1). Their median time to diagnosis was 79 days (IQR: (43–
156) and 62.3% had high AFB loads (++ or +++) (data not shown).
Amongst 355 index cases tested, 14 (3.9%) had a positive HIV
ELISA result and 14 of 289 (4.8%) had multidrug resistant TB.
The median number of persons per household was 5 (IQR 4–6).
No significant differences in age and sexwere found between HHCs
and individuals from the SP (Table 1). Compared to subjects from
the SP, a higher percentage of HHCs were vaccinated with BCG
and had history of TB disease. Amongst those from the SP, 13.2%
recalled having contact with someone with TB and 5.2% reported
having lived with such person (data not shown).
Of 2060 contacts enrolled (Figure 1), 1977 had baseline IFNc
results and 502 also had TST. In the SP, 766/771 (99.3%) subjects
had IFNc and TST results in addition to complete sociodemo-
graphic data. Amongst the 2060 HHCs followed, after two years,
27 (1.3%) were lost to follow-up, 32 (1.6%) dropped out, 37 (1.8%)
developed TB and 34 (1.7%) died from other causes.
Tuberculin Skin Test Reactivity in HHC and Source
Population
Since TST is the traditional method to measure mycobacterial
infections, it was applied to a sample of HHCs and all individuals
from the SP. Using a 10 mm threshold, 65.9% of HHCs were
positive, compared to 42.7% subjects from the SP (OR 2.60, 95%
CI 2.06–3.28, p,0.0001). Using 5 mm cut-off, 77.3% and 49.1%
were TST positive, respectively (OR 3.53 95% CI 2.74–4.54,
p,0.0001). Amongst 146 TST negative subjects at baseline who
were retested after one year, 65 (44.5%) converted using 10 mm
IFNc and TB Prediction
PLoS ONE | www.plosone.org 4 December 2009 | Volume 4 | Issue 12 | e8257threshold and 43 (29.5%) converted according to the ATS/CDC
criterion [32]. Median difference in induration diamaters between
the first TST and the subsequent one after 1 year was 6 mm
(Wilcoxon sign rank test p,0,001).
IFNc Production by HHC and Source Population in
Response to Mycobacterial Antigens
In the last decade IFNc production in response to specific
mycobacterial antigens have received much attention as a more
reliable and specific biomarker of M. tuberculosis infection [26,33].
Thus we compared IFNc production in the two populations in
response to specific CFP-10 antigen [34] as well as to non-specific
Ag85A [35], latency associated HspX [17] and the mixture of
culture filtrate proteins (CFP) as an in vitro equivalent to TST.
Geometric means of IFNc production levels were significantly
(p,0.0001) higher in HHCs than in the SP in response to CFP
(495.9 versus 154.7 pg/mL), CFP-10 (146.3 versus 44.4 pg/mL),
HspX (31.9 versus 12.7 pg/mL), and Ag85A (31.5 versus 11.9 pg/
mL) (Figure 2A). With all antigens assayed, the likelihood of
having a positive IFNc response was higher (p,0.001) in HHCs
than in the SP subjects. With CFP, there were 88.3% positive
HHCs and 72.0% in the SP (OR=2.93 95% CI 2.4–3.6). In
response to CFP-10, 66.3% of HHCs were positive in contrast to
24.5% of the subjects from the SP (OR=6.07 95% CI 5.02–7.33).
IFNc responses to HspX and Ag85A were 32.0% and 30.2% in
HHCs while only 3.9% and 4.2% in the SP (OR=11.7 95% CI
7.6–18.0 and OR=9.96 95% CI 6.9–14.4), respectively
(Figure 2B). As described above, a modification of the IFNc level
categorization proposed by Andersen et al [11] was used to further
analyse the magnitude of IFNc responses and the most striking
difference between the two populations was found in CFP-10
responses, while 49.2% of HHCs presented medium to high levels
of IFNc production, only 12.6% of SP subjects exhibited those two
levels (trend x
2;p ,0.0001) (Figure 2C).
Of note, amongst HHCs who were initially negative for IFNc
production in response to CFP-10, 43.1% became positive when
retested, 42.0% of them with increases $30% of initial values [36].
Thus, taking into account both measurements, HHCs positivities
were 90.1%, 79.4%, 37.8% and 31.6% for CFP, CFP-10, HspX
and Ag85A, respectively.
Effect of Age on IFNc Production and Tuberculin Skin
Test Reactivity
Considering the wide range of age amongst the HHCs and that
responses in young HHCs maybe more conditioned by the recent
exposure to index cases, than in adults in whom past exposure to
other sources cannot be ruled out, it was important to determine
whether IFNc production and TST varied with age, as previously
Table 1. Characteristics of household contacts (HHCs) of pulmonary tuberculosis cases and individuals from their source
population (SP).
Characteristic Index Cases* (n=366) Household Contacts (n=2060) Source Population (n=771) p value{
Sex (%)
Female 43.4 57.2 55.7
Male 56.6 42.8 44.3 0.519
Age (years)
Median (IQR) (%) 36 (24–50) 22 (10–42) 22 (11–46)
#4 0.0 11.5 11.1
5–14 0.0 24.5 23.2
15–24 25.1 18.6 18.1
25–49 49.7 28.5 27.0
50–64 16.9 10.3 15.5
$65 8.2 6.6 5.0 0.295
Socioeconomic Stratum (%){
21 16.2 16.3 18.9
22 47.2 51.7 54.8
23 32.7 28.4 26.1
24 2.8 2.8 0.1
25 0.8 0.7 0.0
26 0.3 0.1 0.0 0,001
BCG scar (%)
Yes 72.2 78.3 73.5
No 27.8 21.7 26.5 0.008
History of tuberculosis prior to study (%)
Yes 10.1 2.5 0.8
No 89.9 97.5 99.2 0.006
*Only index cases that lead to household contacts included.
{p value (two tailed) refers to comparison of characteristics in HHCs and individuals from SP.
{SES categories as defined in Methods.
doi:10.1371/journal.pone.0008257.t001
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CFP-10 were higher in HHCs than the SP in all age groups
(Figure 3). A tendency of mean IFNc responses to CFP to peak in
young adults between 25 and 49 years and decline after 50 years of
age was observed in the two populations studied (Figure 3A). The
same tendency was not observed with CFP-10 in either HHCs or
the SP (Figure 3B). In the SP, IFNc responses to CFP-10 in all age
groups were below the 22pg/mL cut-off.
Correlation of IFNc responses to CFP and CFP-10 (pg/mL)
versus TST (mm induration) were significant in HHCs and the SP
using both antigens (p,0.0001). Overall agreement was higher in
HHCs than in the SP with both antigens. Interestingly, a tendency
of correlation coefficients to decrease with increasing age until 50
or 65 years was observed with both antigens in HHCs (Table 2).
Effect of Exposure to the Index Case on IFNc Production
To assess whether the CFP-10 induced IFNc response was
conditioned by exposure to the index case, positive and negative
responders were compared regarding several markers of exposure
(Table 3). HHCs that had positive baseline IFNc in response to
CFP-10 were more likely than those with negative responses to
have slept in the same room as the index case while symptomatic
without treatment (OR 1.26 p=0.043), to live in households with
less than 12m
2 per person (OR 1.47 p=0.002), and with less air
volume per person (p=0.008 x
2 for trend).
Incidence of Active TB amongst HHC
The overall incidence rate of tuberculosis development in
HHCs was 7.0/1000 person years. The incidence proportion was
highest in children under 5 years of age (Table 4). Twelve of thirty
Figure 2. IFNc production by HHCs and SP. IFNc production in
whole blood cultures stimulated with four mycobacterial antigens in
household contacts and source population. A. IFNc levels produced in
non stimulated and CFP, CFP-10, HspX and Ag85A, stimulated cultures.
B. Bar graphs depicting the percentage of positive responders and OR
in HHCs and SP. C. Stacked bars represent a modification of the IFNc
production levels proposed by Andersen et al [11] showing: Negative:
,22pg/mL, Low: 22–99 pg/mL Medium: 100–999 pg/mL, High:
$1000 pg/mL. HHCs: Household Contacts; SP: Source Population.
doi:10.1371/journal.pone.0008257.g002
Figure 3. IFNc production levels by age. Geometric means of IFNc
production in response to CFP (A) and CFP-10 (B) by age in household
contacts (HHCs) and individuals from source population (SP). Horizontal
lines depict the cut-off value (22 pg/mL).
doi:10.1371/journal.pone.0008257.g003
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(21.6%) under five. Most incident cases (75%) occurred after six
months of follow-up, 40.5% of them shared bedroom with the
index case and only 67.6% had a BCG scar compared to 78.3% in
the whole cohort. Comparison of geometric means of IFNc
produced by incident cases and non-incident HHCs only showed a
significant difference with HspX: 19.2 pg/mL (95% CI 8.3–44.9)
in incident cases versus 35.6 pg/mL (95% CI 32.3–39.1) in non-
incidents (p=0.009) (Table 5).
Predictive Value of IFNc Production on the Development
of Active TB in HHC
To explore whether IFNc production in response specific (CFP-
10) and non-specific (CFP) M. tuberculosis antigens at baseline had a
predictive value, the risk of TB during the first two years of follow-
up was assessed according to IFNc responses as dichotomous and
ordinal outcomes. TB incidence was higher, but not significant
difference was found in positive IFNc responders to CFP-10 in
contrast to negative ones (HR 1.82 95% CI 0.79–4.20 p=0.16).
Using our modification of the IFNc production categories
proposed by Andersen et al [11], almost a 3-fold difference was
found between the highest IFNc producers at baseline compared
with negative responders. Intermediate incidence rates were found
in low and medium categories (Table 6). Further support for this
finding was provided by the significant tendency of increasing
hazard rates of disease development with increasing IFNc
production levels in response to CFP-10 observed during follow-
up (Log Rank for trend p=0.007) (Figure 4B). Disease incidence
was found to be highest in strong responders to CFP-10, whilst
those with medium and low levels of IFNc production had
intermediate incidence levels and the lowest incidence was found
in non responders. Response to CFP was not associated with risk
of developing disease (Figure 4A). Interestingly, within the first two
years after exposure, HHCs with negative IFNc responses to CFP-
10 had low hazard level of disease development and their risk was
distinctly different from the rest. However, from that time point
on, hazard in the lowest responder group rose and at 3 years
became very similar to those in the low and medium response
categories (Figure 4B).
Discussion
Herein we present evidence that levels of IFNc response to
CFP-10 assessed shortly after exposure to an infectious source may
be predictive of tuberculosis development in a population of
HHCs at high risk of infection. To our knowledge, this is the first
population based study to uphold the model posed by Andersen
et al [11]. These authors proposed specific categories of IFNc levels
produced in response to RD1 antigens that identify subgroups at
differential risk of disease development. Several studies have
inquired about the role of IFNc responses to RD1 antigens for
determining the prevalence of M. tuberculosis infection [38–40] and
predicting disease development [13,15,16] in high risk popula-
tions; however, data coming from population based studies with
sufficient power to assess disease prognosis has been limited
[15,16,38]. Albeit our study was performed in a country with an
intermediate level of TB incidence, we consider that the
immunologic profiles associated with high levels of infection and
disease development in HHCs maybe partly explained by a high
intensity of exposure in this population.
Our findings are based on a cohort of HHCs with few losses
and, compared to a representative sample of the SP, both with
sizes large enough to provide an adequate degree of estimate
precision and power. Besides the traditional TST, we used a novel,
though extensively evaluated, biomarker of M. tuberculosis infection:
IFNc response to RD1 antigen CFP-10 and to other mycobac-
terial antigens, particularly Ag85A, HspX and CFP. TST results
Table 2. Correlation between TST and IFNc production in
response to CFP and CFP-10 by age in household contacts
(HHCs) and individuals from source population (SP).
Age HHCs (n=502) SP (n=766)
CFP CFP-10 CFP CFP-10
#4 0.78* 0.74 0.42 0.45
5–14 0.69 0.64 0.48 0.29
15–24 0.44 0.48 0.36 0.26
25–49 0.39 0.42 0.44 0.31
50–64 0.73 0.38 0.57 0.29
$65 0.57 0.45 0.54 0.55
Total 0.58 0.51 0.49 0.30
*Spearman correlation coefficient r. All p values,0.001.
{TST (mm of induration); IFNc (pg/mL).
doi:10.1371/journal.pone.0008257.t002
Table 3. Characteristics associated with baseline levels of
IFNc production in response to CFP-10 in HHCs.
Variable ORGEE* 95% CI p
Sex
Male 1.30 1.08–1.56
Age (years)
#4{ 1.00
5–14 1.89 1.36–2.61 0.0001
15–24 1.68 1.19–2.36 0.003
25–49 1.62 1.18–2.22 0.003
50–64 1.19 0.82–1.75 0.364
$65 1.33 0.85–2.08 0.206
Slept in same room as case 1.26 1.01–1.57 0.043
Crowding{ (3 or more persons per
room)
1.17 0.87–1.58 0.295
Crowding{ (less than 12m
2 per
persons)
1.47 1.15–1.89 0.002
Crowding gradient (m
2/room)1
Greater than 30{ 1.00
21.9–30.0 0.74 0.52–1.06 0.106
16.1–21.8 1.08 0.74–1.56 0.699
16.0 or less 1.04 0.72–1.50 0.838
Crowding (volume per person – m
3)1
50.4 or more{ 1.00
29.4–50.3 0.91 0.63–1.31 0.607
19–29.3 1.18 0.82–1.71 0.368
18.9 or less 1.30 0.90–1.87 0.160
*Crude Odds Ratios adjusted for intra-household correlations with Generalized
Estimating Equations (assumptions: exchangeable matrix, logit link function
and binomial family).
{Reference category.
{According to definition identified in reference [53].
1Categories are quartiles of the air volume distribution.
doi:10.1371/journal.pone.0008257.t003
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the two populations and IFNc production in response to all
antigens assessed was significantly higher in HHCs than in SP.
The observation of similar estimates of M. tuberculosis infection
when TST and IGRA for CFP-10 are used in HHCs but lower
positivity with IFNc response to CFP-10 in SP support that IFNc
measurement has higher specificity than TST, as has been
extensively reported [12,39,41–45]. The consistently positive
association of exposure related variables with positive IFNc
responses to CFP-10 indicates that M. tuberculosis may be
responsible for such responses. In addition, the predominantly
medium and high IFNc production levels in response to CFP-10
found in HHCs, in contrast to mostly low and negative responses
in the SP strongly suggest that mycobacterial stimulation in HHCs
is predominantly driven by M. tuberculosis.
Exploration of IFNc variations by age revealed a trend to
increase responses up to adulthood with CFP, but not with CFP-
10 in both HHCs and SP. This finding suggests that cumulative
exposure to environmental mycobacteria and M. bovis BCG
vaccination, besides M. tuberculosis, plays a role in determining
responses to CFP, but not to the M. tuberculosis specific antigen
CFP-10. In fact, IFNc responses to CFP-10 in HHCs were above
the cut-off point in subjects of all ages, but always below it in the
SP. This differential pattern shows the ability of CFP-10 responses
to discriminate between the risk of exposure to M. tuberculosis in
HHCs and the SP, irrespective of age. The observation that IFNc
responses to CFP-10 by age failed to show a trend and that
children exhibit IFNc responses as high as those in young and old
adults, confirms previous observations in Ugandan HHCs [45].
Additionally, in HHCs, correlations of IFNc levels in response
to CFP-10 and CFP, and TST indurations by age were highest in
children in whom recent exposure to the index case is
predominant. In contrast, in the SP the best correlations were
found in the older age groups in whom cumulative exposure to M.
tuberculosis, or other mycobacteria in the case of CFP induced
responses, is likely to be highest. This provides further evidence of
the M. tuberculosis specific nature of the responses to CFP-10.
An important difference between our study and others that have
been performed using IFNc responses is that the in-house assay
performed by us incorporates a 7 day whole blood culture in
contrast to the 24h incubation commonly used by commercial
IGRAs [46,47]. By virtue of the extended lymphocyte culture
times used herein, these measures may primarily detect central
memory responses while short incubation IGRAs commonly used,
detect mostly effector memory T cell responses of recently
activated lymphocytes [48,49] [Marı ´n et al. manuscript in
preparation]. It has been argued that, in settings of high
endemicity where a mixture of recent and old infections are
commonly found, long term assays are more sensitive than those
with shorter culture times [48]. Thus the incubation time used in
our study may contribute to account for the high levels of IFNc
responses to CFP-10 observed in HHCs and the establishment of
latent tuberculosis infection amongst HHCs.
The main goal of our study was to establish the value of IFNc
responses to CFP-10 as prognostic marker of tuberculosis disease
development. Except for HspX-induced responses, univariate and
bivariate analyses of IFNc baseline levels did not show significant
differences between incident and non-incident HHCs (Table 5).
However, during the course of this study, Andersen et al [11]
proposed a model in which IFNc responses to RD1 antigens can
be categorized in low, medium and high, where higher producers
are at increased risk of disease development. Thus, we modified
such categories adding a fourth level of negative responders
(#22 pg/mL) based on the cut-off value taking into account the
Table 4. Incidence of active tuberculosis in household contacts according to age.
Age N Cases Percentage of TB cases Incidence proportion Person-years
Incidence rate (#/1000
person-years)
#4 237 8 21.6 3.4 619.9 12.9
5–14 505 4 10.8 0.8 1342.0 3.0
15–24 381 7 18.9 1.8 985.5 7.1
25–49 585 7 18.9 1.2 1498.0 4.5
50–64 209 7 18.9 3.3 510.8 13.1
$65 135 4 10.8 3.0 315.3 10.6
Total 2052 37 100.0 1.8 5272.3 7.0
doi:10.1371/journal.pone.0008257.t004
Table 5. Comparison of baseline IFNc production by TB incident and non–incident HHCs in response to the antigens used.
Antigen Geometric Mean (CI 95%) Geometric Mean (CI 95%) % (n/n) % (n/n) x
2{
Incident Non-incident p value* Incident Non-incident p value
CFP 562.7 (324.7–975.1) 554.5 (515.3–596.7) 0.958 87.9 (29/33) 88.3 (1704/1929) 0.935
CFP-10 248.9 (133.9–462.6) 188.8(174.4–204.4) 0.278 78.8 (26/33) 66.0 (1281/1940) 0.124
HspX 19.2 (8.3–44.9) 35.6 (32.3–39.1) 0.009 33.3 (11/33) 32.0 (611/1912) 0.866
Ag85A 29.2 (12.5–68.0) 34.5 (31.0–38.3) 0.549 39.4 (13/33) 30.1 (583/1940) 0.246
*Student t - test.
{Chi-square (x
2) test.
doi:10.1371/journal.pone.0008257.t005
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Strikingly, we found a significant trend to increase incidence of
tuberculosis with increasing levels of CFP-10-induced IFNc, but
not with CFP. The marked differences in risk of disease
progression in the negative responder group compared to the rest
during the first 2 years, suggest that indeed these HHCs were not
infected and shows the added value provided by this categoriza-
tion. Interestingly, after 2 years post-exposure, the cumulative
incidence in non-responders levelled out with those of low and
medium IFNc producers. The reasons why risk levels become
similar after the first 24 months is unclear. We explored differences
among subjects in the negative response group regarding
socioeconomic, demographic and epidemiologically relevant
variables but significant differences were not found (data not
shown). Possible explanations for levelling out of risks of disease
development in subjects with different levels of IFNc production in
response to CFP-10 could be related to M. tuberculosis re-exposures
and slow responses due to co morbidities.
The more detailed assessment of the evolution of IFNc levels
produced by incident cases and non-incident HHCs in response to
CFP and CFP-10 is in agreement with the model proposed by
Andersen et al [11]. These authors proposed three stages in
tuberculosis immunopathogenesis following M. tuberculosis infec-
tion: an initial phase of incipient disease characterized by a small
peak of IFNc production in response to RD1 antigens, which in
those that initially control the bacillus, is followed by a decline and
subsequent plateau of IFNc levels throughout the duration of
bacterial latency, only to rise again and reach the highest levels
when active disease ensues. A few studies support this issue
[50,51]. Although our data provide support for the concept that
high levels of IFNc in response to RD1 antigens after exposure are
indicative of higher risk of disease development during the first 2
years post exposure, the observation that most incident cases
occurred 6–24 months after the diagnosis of the index case is not
fully in line with the reasoning [11] which proposes that this model
holds only for short term progressions to overt disease. In the case
of child HHCs the exposure to the index case most probably
resulted in primary infection and in a high proportion of them in
post-primary disease. The high levels of conversions by TST and
IGRA, as well as the high disease incidence rate ratios observed in
children, suggest that a high proportion of disease may be due to
recent transmission. In adult HHCs such exposure may result in
reinfection, making it likely that a large proportion of our incident
adult cases were due to reinfections rather than to reactivations.
Besides exploring responses to CFP-10 and CFP, we also
assessed responses to antigens HspX and Ag85A. We found the
greatest difference in IFNc responses between HHCs and SP was
marked by HspX and followed closely by Ag85A. The differences
Table 6. Incidence of active tuberculosis in household contacts and IFNc production levels at baseline.
IFNc production* N Cases Percentage of TB cases Incidence Proportion Person-years
Incidence Rate (#/1000
person-years)
Negative 666 7 21.2 1.05 1686.9 4.1
Low 338 6 18.2 1.78 857.9 7.0
Medium 688 12 36.4 1.74 1798.1 6.7
High 281 8 24.2 2.85 703.5 11.4
Total Positive{ 1307 26 78.8 1.99 3359.6 7.7
*Negative: ,22pg/mL, Low: 22–99 pg/mL Medium: 100–999 pg/mL, High: $1000 pg/mL.
{Total positive: (Negative + Low + Medium + High).
doi:10.1371/journal.pone.0008257.t006
Figure 4. Hazard of TB development according to IFNc
production. Hazard levels of tuberculosis development taking the
modified version of IFNc production categories proposed by Andersen
et al [11] as baseline predictors of disease. Negative: ,22pg/mL, Low:
22–99 pg/mL Medium: 100–999 pg/mL, High: $1000 pg/mL. HHCs:
Household Contacts SP: Source Population.
doi:10.1371/journal.pone.0008257.g004
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maintaining latency, but the reasons for the large differences in
responses to Ag85A remain unclear to us. It must be noted that for
stimulation in whole blood cultures we used recombinant proteins
rather than peptides; however, Arend et al compared the response
to the two type of CFP-10 preparations and found them to be
equivalent [52]. In addition, though epitope mapping has been
performed for these antigens, it is possible that other epitopes are
present in the proteins. In whole blood cultures the use of proteins
does not require the differentiation of MHC-I vs. MHC-II
epitopes, which determines the response to particular peptides.
Furthermore, in an in vitro T cell stimulation assay such as the
one performed in this cohort, whole proteins typically give a
more robust response than peptides (John T. Belisle personal
communication).
Given the very high rates of tuberculosis development observed
in children and the fact that we could not offer them IPT, as
recommended by several international guidelines [29–31], the
ethical implications of this study is a highly relevant issue.
However, according to the Colombian TB Control Program [28]
IPT can only be provided to children under 5 years of age with
$10 mm induration in the TST test, no BCG vaccination,
conditions that were not met by any of this cohort’s children. In
addition, the administration of all anti-TB treatments is restricted
to the government operated TB Control program, a reason why
our research team was unable to provide it.
We consider that, in spite of not being able to provide
prophylaxis to children less than 5 years, our results serve to
increase the visibility of this vulnerable population subgroup.
Twenty two percent of incident cases in our study were children
#4 years compared to only 3% of this age group detected through
regular surveillance activities in Medellı ´n (http://www.dssa.gov.
co/htm/inciden.htm). Even though we did not offer IPT, we
closely followed the cohort members resulting in a reduction of the
median diagnostic delay from 2.6 months in index cases to 1.0
month in incident cases (data not shown). In addition, the results
clearly demonstrate the high risk of infection and disease
development in child HHCs. We consider that this finding
underscores the need to focus on this population subgroup and
strengthen contact tracing activities. Since this message was
delivered by members of our group to health authorities in several
occasions, Colombian health authorities decided to change the
national health regulations to allow the provision of tuberculosis
IPT to all child contacts less than 5 years of age regardless of
vaccination status (statement issued by the Public Health Director
of the Colombian Ministry of Social Protection).
Taken together our results clearly demonstrate that HHCs are a
population at high risk of infection and disease development and
show a marked difference in the risk of tuberculosis development
depending on the levels of IFNc production in response to CFP-10
shortly after exposure to M. tuberculosis. Since the identification of
close contacts at highest risk of disease development is a highly
desirable tool for more efficient tuberculosis control, the results
presented herein constitute a remarkable step forward in the
search for a biomarker of disease prognosis and open up the
possibility of providing targeted IPT administration to child
contacts based on IFNc production in response to CFP-10
antigen.
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